The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial Infections
Abstract
The distinction between bactericidal and bacteriostatic agents appears to be clear according to the in vitro definition, but this only applies under strict laboratory conditions and is inconsistent for a particular agent against all bacteria. The distinction is more arbitrary when agents are categorized in clinical situations. The supposed superiority of bactericidal agents over bacteriostatic agents is of little relevance when treating the vast majority of infections with gram-positive bacteria, particularly in patients with uncomplicated infections and noncompromised immune systems. Bacteriostatic agents (e.g., chloramphenicol, clindamycin, and linezolid) have been effectively used for treatment of endocarditis, meningitis, and osteomyelitis--indications that are often considered to require bactericidal activity. Although bacteriostatic/bactericidal data may provide valuable information on the potential action of antibacterial agents in vitro, it is necessary to combine this information with pharmacokinetic and pharmacodynamic data to provide more meaningful prediction of efficacy in vivo. The ultimate guide to treatment of any infection must be clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Pizzo, P. A., Hathorn, J. W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150905 · Cited by 585
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00227-x · Cited by 494
Bacterial Meningitis: Pathogenesis, Pathophysiology, and Progress
Epstein, F. H., Quagliarello, V., & Scheld, W. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209173271208 · Cited by 488
Stevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473
Current Clinical Topics in Infectious Diseases
(1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150042013 · Cited by 471
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90358-9 · Cited by 418
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.
Durack, D. T., & Beeson, P. B. (1972) · PubMed · Cited by 355
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria
Eng, R. H., Padberg, F. T., Smith, S. M., Tan, E. N., & Cherubin, C. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1824 · Cited by 350
First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
Ploy, M., Grelaud, C., Martin, C., de Lumley, L., & Denis, F. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79166-2 · Cited by 331
ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITS
Fridkin, S. K., & Gaynes, R. P. (1999) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70143-x · Cited by 325
Kinetics of antimicrobial activity
Vogelman, B., & Craig, W. A. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80754-5 · Cited by 315
A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS
(1977) · InPharma · doi:10.1007/bf03284982 · Cited by 253
Nau, R., & Eiffert, H. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.95-110.2002 · Cited by 240
Bacterial Adherence and the Glycocalyx and Their Role in Musculoskeletal Infection
Gristina, A. G., & Costerton, J. W. (1984) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)31101-9 · Cited by 232
Taylor, P. C., Schoenknecht, F. D., Sherris, J. C., & Linner, E. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.142 · Cited by 213
Antibiotic tolerance among clinical isolates of bacteria
Tuomanen, E., Durack, D. T., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.521 · Cited by 212
Antibiotic Tolerance Among Clinical Isolates of Bacteria
Handwerger, S., & Tomasz, A. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.3.368 · Cited by 206
A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS
Sabath, L. D., Laverdiere, M., Wheeler, N., Blazevic, D., & Wilkinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91941-9 · Cited by 205
Self-citationNalidixic Acid: an Antibacterial Paradox
Crumplin, G. C., & Smith, J. T. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.251 · Cited by 194
The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
Hiramatsu, K. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00149-1 · Cited by 191
Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis
Friedland, I. R., Klugman, K. P., & Klugman, K. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90087-j · Cited by 191
Jackson, J. J., & Kropp, H. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.6.1033 · Cited by 183
Mayberry-Carson, K. J., Tober-Meyer, B., Smith, J. K., Lambe, D. W., & Costerton, J. W. (1984) · Infection and Immunity · doi:10.1128/iai.43.3.825-833.1984 · Cited by 172
Phenotypic Tolerance: The Search for β-Lactam Antibiotics That Kill Nongrowing Bacteria
Tuomanen, E. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_3.s279 · Cited by 172
Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus
Sande, M. A., & Johnson, M. L. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.4.367 · Cited by 158
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance
Peterson, L. R., & Shanholtzer, C. J. (1992) · Clinical Microbiology Reviews · doi:10.1128/cmr.5.4.420 · Cited by 156
INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS
Musher, D. M., & McKENZIE, S. O. (1977) · Medicine · doi:10.1097/00005792-197709000-00002 · Cited by 149
Zeana, C. B., Kubin, C. J., Della‐Latta, P., & Hammer, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/321896 · Cited by 138
A Practical Approach to Infectious Diseases.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-431_4 · Cited by 137
Stevens, D. L., Maier, K. A., Laine, B. M., & Mitten, J. E. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.2.220 · Cited by 137
THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN
Eagle, H., & Musselman, A. D. (1949) · Journal of Bacteriology · doi:10.1128/jb.58.4.475-490.1949 · Cited by 129
Trimethoprim-Sulfamethoxazole for Bacterial Meningitis
Levitz, R. E., & QUINTILIANI, R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-881 · Cited by 126
Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid
Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S. (2001) · Clinical Infectious Diseases · doi:10.1086/319986 · Cited by 113
Quinupristin/Dalfopristin: A Review of its Use in the Management of Serious Gram-Positive Infections
Lamb, H. M., Figgitt, D. P., & Faulds, D. M. (1999) · Drugs · doi:10.2165/00003495-199958060-00008 · Cited by 109
Clindamycin therapy of staphylococcus aureus endocarditis
Watanakunakorn, C. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90758-0 · Cited by 106
Chemistry and Mechanisms of Action of the Quinolone Antibacterials
Smith, J. T., & Lewin, C. S. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-059515-0.50006-8 · Cited by 103
Serious Staphylococcal Infections With Strains Tolerant to Bactericidal Antibiotics
Denny, A. E., Peterson, L. R., Gerding, D. N., & Hall, W. H. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630460058018 · Cited by 98
Shear, N., & Litt, J. Z. (2004) · CRC Press eBooks · doi:10.3109/9780203492079-157 · Cited by 93
Cantoni, L., Glauser, M. P., & Billé, J. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2348 · Cited by 89
Moise, P. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf215 · Cited by 89
Mustafa, M. M., Mertsola, J., Ramilo, O., Sáez‐Llorens, X., Risser, R. C., & McCracken, G. H. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.891 · Cited by 82
SPECULATIONS ON THE MECHANISM OF CURE OF BACTERIAL ENDOCARDITIS
HUNTER, T. H. (1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02920070012004 · Cited by 78
Problems in in vitro determination of antibiotic tolerance in clinical isolates
Sherris, J. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.5.633 · Cited by 76
Concept of empiric therapy with antibiotic combinations. Indications and limits.
Klastersky, J. A. (1986) · PubMed · Cited by 75
Quinupristin‐Dalfopristin: An Overview
Delgado, G., Neuhauser, M. M., Bearden, D. T., & Danziger, L. H. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1469.34858 · Cited by 72
Action of Penicillin on Bacteria
Garrod, L. P. (1945) · BMJ · doi:10.1136/bmj.1.4386.107 · Cited by 67
Bostic, G. D., Perri, M. B., Thal, L. A., et al. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00210-1 · Cited by 66
Kim, K. S., & Anthony, B. F. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.6.1075 · Cited by 61
Peterson, L. R., Gerding, D. N., Hall, W. H., & Schierl, E. A. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.4.665 · Cited by 51
Clindamycin in the Treatment of Streptococcal and Staphylococcal Toxic Shock Syndromes
Russell, N. E., & Pachorek, R. E. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19095 · Cited by 51
van Langevelde, P., van Dissel, J. T., Meurs, C. J. C., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1682 · Cited by 43
Review of Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents
Estes, L. L. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.11.1114 · Cited by 38
Lambe, D. W., Mayberry-Carson, K. J., Ferguson, K. P., & Costerton, J. W. (1984) · Canadian Journal of Microbiology · doi:10.1139/m84-124 · Cited by 29
Lamp, K. C., & Rybak, M. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.605 · Cited by 28
Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis
van Asselt, G. J., Mouton, R. P., & van Boven, C. P. A. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01591482 · Cited by 28
Kj, M.-C., Tober-Meyer, B., Dw, L., et al. (1986) · PubMed · Cited by 27
Phenotypic resistance to antimicrobial agents
Greenwood, D. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.6.653 · Cited by 26
Paradoxical effect of penicillin in-vivo
Griffiths, L. R., & Green, H. T. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.4.507 · Cited by 15
Sullam, P. M., Drake, T. A., Täuber, M. G., Hackbarth, C. J., & Sande, M. A. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.320 · Cited by 13
Dankert, J., Holloway, Y., Joldersma, W., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.4.614 · Cited by 10
Cited by
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Agnihotri, S., Mukherji, S., & Mukherji, S. (2014) · RSC Adv. · doi:10.1039/c3ra44507k · Cited by 1,872
Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,127
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.057 · Cited by 862
Metadata
- Authors
- Pankey, G. A., & Sabath, L. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-15
- Volume
- 38
- Issue
- 6
- Pages
- 864-870
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2147652807
- Cited by
- 1,201
- References
- 68
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.